Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970 - 2006

BMC Psychiatry

Volumn 11, Issue , 2011, Pages

  Nyhlén, Anna ^a   Fridell, Mats ^a   Bäckström, Martin ^a   Hesse, Morten ^b   Krantz, Peter ^a  

^a LUND UNIVERSITY   (Sweden)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Cohort study; Competing risks Cox regression; Drug related death; Gender; Predictors; Risk factor

Indexed keywords

BARBITURIC ACID DERIVATIVE; CANNABIS; CENTRAL STIMULANT AGENT; HYPNOTIC AGENT; OPIATE DERIVATIVE; PSYCHEDELIC AGENT; SEDATIVE AGENT;

ADOLESCENT; ADULT; AGED; ALCOHOL ABUSE; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; CANNABIS ADDICTION; CAUSE OF DEATH; COMORBIDITY; DEATH; DEPRESSION; DRUG DEPENDENCE; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORTALITY; NEUROSIS; OPIATE ADDICTION; PERSONALITY DISORDER; PREDICTOR VARIABLE; PREMATURE DEATH; PROSPECTIVE STUDY; PSYCHOSIS; RISK ASSESSMENT; SEX DIFFERENCE; SUBSTANCE ABUSE; SWEDEN; ADDICTION; INTERNATIONAL CLASSIFICATION OF DISEASES; MIDDLE AGED; PREMATURE MORTALITY; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL ASPECT; RISK FACTOR;

ADOLESCENT; ADULT; AGED; CAUSE OF DEATH; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MENTAL DISORDERS; MIDDLE AGED; MORTALITY, PREMATURE; PROSPECTIVE STUDIES; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; SWEDEN;

EID: 79960880956     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-11-122     Document Type: Article

References (43)

1. Bejerot N. Drug abuse and drug policy. An epidemiological and methodological study of drug abuse of intravenous type in the Stockholm police arrest population 1965--1970 in relation to changes in drug policy. Acta Psychiatrica Scandinavica 1975, 256(Suppl):3-277.
2. Frykholm B. Changes in short-term prognosis-a comparison between Swedish amphetamine and opiate abusers. Drug and Alcohol Dependence 1980, 5(2):123-8. 10.1016/0376-8716(80)90188-X, 7353470.
3. Bartu A, Freeman NC, Gawthorne GS, et al. Mortality in a cohort of opiate and amphetamine users in Perth, Western Australia. Addiction 2004, 99(1):53-60. 10.1111/j.1360-0443.2004.00602.x, 14678062.
4. Wahren CA, Brandt L, Allebeck P. Has mortality in drug addicts increased? A comparison of two hospitalized cohorts in Stockholm. International Journal of Epidemiology 1997, 26(6):1219-1226. 10.1093/ije/26.6.1219, 9447401.
5. Barr HL, Antes D, Ottenberg DJ, Rosen A. Mortality of treated alcoholics and drug addicts: the benefits of abstinence. Journal of Studies on Alcohol 1984, 45(5):440-52.
6. Tunving K. Fatal outcome in drug addiction. Acta Psychiatrica Scandinavica 1988, 77(5):551-66. 10.1111/j.1600-0447.1988.tb05168.x, 3407425.
7. Skurtveit S, Christophersen AS, Grung M, Morland J. Increased mortality among previously apprehended drunken and drugged drivers. Drug and Alcohol Dependence 2002, 68(2):143-150. 10.1016/S0376-8716(02)00185-0, 12234643.
8. Chen CC, Kuo CJ, Tsai SY. Causes of death of patients with substance dependence: a record-linkage study in a psychiatric hospital in Taiwan. Addiction 2001, 96(5):729-36. 10.1046/j.1360-0443.2001.9657298.x, 11331031.
9. Sørensen HJ, Jepsen PW, Haastrup S, Juel K. Drug-use pattern, comorbid psychosis and mortality in people with a history of opioid addiction. Acta Psychiatrica Scandinavica 2005, 111:244-249. 10.1111/j.1600-0447.2004.00445.x, 15701109.
10. Copeland L, Budd J, Robertson JR, Elton RA. Changing patterns in causes of death in a cohort of injecting drug users, 1980-2001. Archives of Internal Medicine 2004, 164(11):1214-20. 10.1001/archinte.164.11.1214, 15197047.
11. Risser D, Honigschnabl S, Stichenwirth M, et al. Mortality of opiate users in Vienna, Austria. Drug Alcohol Dependence 2001, 64(3):251-6.
12. Rehm J, Frick U, Hartwig C, et al. Mortality in heroin-assisted treatment in Switzerland 1994-2000. Drug and Alcohol Dependence 2005, 79(2):137-43. 10.1016/j.drugalcdep.2005.01.005, 16002023.
13. Degenhardt LJ, Roxburgh A, Barker B. Underlying causes of cocaine, amphetamine and opioid related deaths in Australia. Journal of Clinical Forensic Medicine 2005, 12(4):187-195. 10.1016/j.jcfm.2004.11.003, 16054006.
14. Brugal MT, Domingo-Salvany A, Puig R, et al. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction 2005, 100(7):981-9. 10.1111/j.1360-0443.2005.01089.x, 15955014.
15. Gossop M, Stewart D, Treacy S, Marsden J. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction 2002, 97(1):39-47. 10.1046/j.1360-0443.2002.00079.x, 11895269.
16. Oppenheimer E, Tobutt C, Taylor C, Andrew T. Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study. Addiction 1994, 89(10):1299-308. 10.1111/j.1360-0443.1994.tb03309.x, 7804091.
17. Ghodse AH, Oyefeso A, Kilpatrick B. Mortality of drug addicts in the United Kingdom 1967-1993. International Journal of Epidemiology 1998, 27:473-478. 10.1093/ije/27.3.473, 9698138.
18. Frischer M, Bloor M, Goldberg D, et al. Mortality among injecting drug users: a critical reappraisal. Journal of Epidemiology and Community Health 1993, 47:59-63. 10.1136/jech.47.1.59, 1059713, 8436897.
19. Fridell M, Hesse M, Jaeger MM, Kühlhorn E. Antisocial personality disorder as a predictor of criminal behaviour in a longitudinal study of a cohort of abusers of several classes of drugs: relation to type of substance and type of crime. Addictive Behaviours 2008, 33(6):799-811.
20. Schifano F, Corkery J, Naidoo V, Oyefeso A, Ghodse H. Overview of amphetamine- type stimulant mortality data -UK, 1997-2007. Neuropsychobiology 2010, 61(3):122-130. 10.1159/000279302, 20110737.
21. Oyefeso A, Schifano F, Ghodse H, et al. Fatal injuries while under the influence of psychoactive drugs: a cross-sectional exploratory study in England. BMC Public Health 2006, 6;6:148.
22. Fridell M, Hesse M. Psychiatric severity and mortality in substance abusers: a 15-year follow-up of drug users. Addictive Behaviours 2006, 31(4):559-65.
23. Tungt narkotikamissbruk. En särredovisning för län och kommuner av 1979-års undersökning. UNO, Heavy drug use: A special report for counties and municipalities of the 1979 study 1980, Stockholm, Liber förlag.
24. Berglund GW, Bergmark A, Björling B, et al. The SWEDATE Project: interaction between treatment, client background, and outcome in a one-year follow-up. Journal of Substance Abuse Treatment 1991, 8(3):161-9. 10.1016/0740-5472(91)90008-X, 1660080.
25. The ICD-10 classification of mental and behavioural disorders and somatic diseases 1993, Geneva, WHO.
26. Bargagli AM, Hickman M, Davoli M, et al. Drug-related mortality and its impact on adult mortality in eight European countries. European Journal of Public Health 2006, 16(2):198-202.
27. Pintilie M. Analysing and interpreting competing risk data. Statistics in Medicine 2007, 26(6):1360-7. 10.1002/sim.2655, 16900575.
28. Swedish Central Bureau of Statistics, SCB 1980, Sweden, SCB, SCB 2006., http://www.scb.se
29. EMCDDA Drug related deaths and mortality. Annual report on the state of the drugs problem in Europe/EMCDDA 2010, 87-92. Lisbon, EMCDDA.
30. Ravndal E, Vaglum P. Overdoses and suicide attempts: different relations to psychopathology and substance abuse? A five-year prospective study of drug abusers. European Addiction Research 1999, 5(2):63-70. 10.1159/000018967, 10394035.
31. Hulse GK, English DR, Milne E, Holman CDJ. The quantification of mortality resulting from the regular use of illicit opiates. Addiction 1999, 94(2):221-9. 10.1046/j.1360-0443.1999.9422216.x, 10396790.
32. Darke S, Zador D. Fatal heroin overdose: a review. Addiction 1996, 91(12):1765-1772. 10.1111/j.1360-0443.1996.tb03800.x, 8997759.
33. White JM, Irvine RJ. Mechanisms of fatal opioid overdose. Addiction 1999, 94:961-972. 10.1046/j.1360-0443.1999.9479612.x, 10707430.
34. Andreasson S, Allebeck P. Cannabis and mortality among young men: a longitudinal study of Swedish conscripts. Scandinavian Journal of Social Medicine 1990, 18(1):9-15.
35. Sidney S, Beck JE, Tekawa IS, et al. Marijuana use and mortality. American Journal of Public Health 1997, 87(4):585-90. 10.2105/AJPH.87.4.585, 1380837, 9146436.
36. Hser Y-I, Hoffman V, Grella CE, Anglin MD. A 33 year follow-up of narcotics addicts. Archives of General Psychiatry 2001, (58):503-508.
37. Baldacchino A, Corkery J. Comorbidity research in Europe. European Collaborating Centres in Addiction Studies (ECCAS) ECCAS Monograph Series no 4 2006, 307-330. London.
38. Nilsson M, Fridell M, Griffiths P. Comorbidity-developing an European perspective. European Collaborating Centres in Addiction Studies (ECCAS) ECCAS Monograph Series no 4 2006, 351-363. London.
39. Bogren M, Mattisson C, Isberg P-E, Nettelbladt P. How common are psychotic and bipolar disorders? A 50-year follw-up of the Lundby population. Nordic Journal of Psychiatry 2009, (63):336-346.
40. Nettelbladt P, Bogren M, Mattisson C, et al. Does it make sense to do repeated surveys?-the Lundby Study, 1947-1997. Acta Psychiatrica Scandinavica 2005, (111):444-452.
41. Nyhlén A, Fridell M, Hesse M, Krantz P. Causes of premature mortality in Swedish drug abusers: A prospective longitudinal study 1970-2006. Journal of Forensic and Legal Medicine 2011, 18:66-72. 10.1016/j.jflm.2011.01.003, 21315300.
42. Di Castelnuovo A, Costanzo S, Bagnardi V, et al. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Archives of Internal Medicine 2006, 166(22):2437-45. 10.1001/archinte.166.22.2437, 17159008.
43. Szasz T. The Discovery of drug addiction. Ceremonial Chemistry 1974, 3-18. Anchor Press; New York.